Belimumab ameliorates symptoms and disease activity in patients with dermatomyositis and juvenile dermatomyositis refractory to standard therapy: A retrospective observational study

Authors:

Abstract
No abstract available
Funding Information
  • National Natural Science Foundation of China
  • National Key Research and Development Program of China Stem Cell and Translational Research
  • Changsha Science and Technology Bureau
  • Hunan Provincial Natural Science Foundation
  • Department of Science and Technology of Hunan Province